Haemonetics (NYSE:HAE) Cut to Underperform at Bank of America
Bank of America lowered shares of Haemonetics (NYSE:HAE – Free Report) from a neutral rating to an underperform rating in a research report released on Friday, MarketBeat.com reports. The firm currently has $68.00 price target on the medical instruments supplier’s stock, down from their previous price target of $95.00. Several other research analysts have also […]
Bank of America lowered shares of Haemonetics (NYSE:HAE – Free Report) from a neutral rating to an underperform rating in a research report released on Friday, MarketBeat.com reports. The firm currently has $68.00 price target on the medical instruments supplier’s stock, down from their previous price target of $95.00. Several other research analysts have also […]
